Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony D Ho

Showing results (271-280 of 346) with videos related to

Pageof 35
Sort By:
Experimental Hematology|March 30, 2006
The heterogeneity of human mesenchymal stem cell preparations--evidence from simultaneous analysis of proteomes and transcriptomesWolfgang Wagner, Robert E Feldmann, Anja Seckinger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2020
Feasibility and Safety of CD19 Chimeric Antigen Receptor T Cell Treatment for B Cell Lymphoma Relapse after Allogeneic Hematopoietic Stem Cell TransplantationMaria-Luisa Schubert, Sascha Dietrich, Stephan Stilgenbauer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 2, 2009
Melan-A/MART1 analog peptide triggers anti-myeloma T-cells through crossreactivity with HM1.24Olaf Christensen, Alaviana Lupu, Stefanie Schmidt, et al.
Scientific Reports|July 16, 2020
Glycogen accumulation, central carbon metabolism, and aging of hematopoietic stem and progenitor cellsLaura Poisa-Beiro, Judith Thoma, Jonathan Landry, et al.
British Journal of Haematology|March 19, 2016
Increased microcirculation detected by dynamic contrast-enhanced magnetic resonance imaging is of prognostic significance in asymptomatic myelomaJens Hillengass, Judith Ritsch, Maximilian Merz, et al.
Ebiomedicine|June 10, 2018
Distinct Activities of Glycolytic Enzymes Identify Chronic Lymphocytic Leukemia Patients with a more Aggressive Course and Resistance to Chemo-ImmunotherapyGeorg Gdynia, Tadeusz Robak, Jürgen Kopitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2010
Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myelomaJens Hillengass, Kerstin Fechtner, Marc-André Weber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Clonal heterogeneity as detected by metaphase karyotyping is an indicator of poor prognosis in acute myeloid leukemiaTilmann Bochtler, Friedrich Stölzel, Christoph E Heilig, et al.
Molecular Systems Biology|January 27, 2017
Protein abundance of AKT and ERK pathway components governs cell type-specific regulation of proliferationLorenz Adlung, Sandip Kar, Marie-Christine Wagner, et al.
European Journal of Haematology|March 28, 2008
Identification of HLA-A2 restricted T-cell epitopes within the conserved region of the immunoglobulin G heavy-chain in patients with multiple myelomaSebastian Belle, Fang Han, Maud Condomines, et al.
Pageof 35

Showing results (271-280 of 346) with videos related to

Sort By:
Pageof 35
Experimental Hematology|March 30, 2006
The heterogeneity of human mesenchymal stem cell preparations--evidence from simultaneous analysis of proteomes and transcriptomesWolfgang Wagner, Robert E Feldmann, Anja Seckinger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2020
Feasibility and Safety of CD19 Chimeric Antigen Receptor T Cell Treatment for B Cell Lymphoma Relapse after Allogeneic Hematopoietic Stem Cell TransplantationMaria-Luisa Schubert, Sascha Dietrich, Stephan Stilgenbauer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 2, 2009
Melan-A/MART1 analog peptide triggers anti-myeloma T-cells through crossreactivity with HM1.24Olaf Christensen, Alaviana Lupu, Stefanie Schmidt, et al.
Scientific Reports|July 16, 2020
Glycogen accumulation, central carbon metabolism, and aging of hematopoietic stem and progenitor cellsLaura Poisa-Beiro, Judith Thoma, Jonathan Landry, et al.
British Journal of Haematology|March 19, 2016
Increased microcirculation detected by dynamic contrast-enhanced magnetic resonance imaging is of prognostic significance in asymptomatic myelomaJens Hillengass, Judith Ritsch, Maximilian Merz, et al.
Ebiomedicine|June 10, 2018
Distinct Activities of Glycolytic Enzymes Identify Chronic Lymphocytic Leukemia Patients with a more Aggressive Course and Resistance to Chemo-ImmunotherapyGeorg Gdynia, Tadeusz Robak, Jürgen Kopitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2010
Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myelomaJens Hillengass, Kerstin Fechtner, Marc-André Weber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Clonal heterogeneity as detected by metaphase karyotyping is an indicator of poor prognosis in acute myeloid leukemiaTilmann Bochtler, Friedrich Stölzel, Christoph E Heilig, et al.
Molecular Systems Biology|January 27, 2017
Protein abundance of AKT and ERK pathway components governs cell type-specific regulation of proliferationLorenz Adlung, Sandip Kar, Marie-Christine Wagner, et al.
European Journal of Haematology|March 28, 2008
Identification of HLA-A2 restricted T-cell epitopes within the conserved region of the immunoglobulin G heavy-chain in patients with multiple myelomaSebastian Belle, Fang Han, Maud Condomines, et al.
Pageof 35